NCT05921812
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Sohag University Sohag, Egypt
Clinical trial condition
Non-Hodgkin Lymphoma
Explore clinical trials studying Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
214 public trials
63 recruiting studies
Non-Hodgkin Lymphoma trial results
NCT06203652
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +9 more
- Locations
-
- Zhongshan Hospital，Fudan University Shanghai, Shanghai Municipality, China
NCT04227015
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
Not Yet Recruiting
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
NCT07254793
- Conditions
- Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), +31 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
NCT07679919
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
- Locations
-
- Taussig Cancer Institute | Cleveland Clinic Cleveland, Ohio, United States
Not Yet Recruiting
Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma
NCT07614035
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- IRCCS Policlinico di Sant'Orsola Bologna, Emilia-Romagna, Italy
Not Yet Recruiting
Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
NCT06720701
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
NCT03713580
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT04000880
- Conditions
- Adnexal Diseases, Behavior, Blood Protein Disorders, +67 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Tennessee Health Science Center Memphis, Tennessee, United States